tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Perseus Proteomics and UBE’s New ADC Collaboration

Perseus Proteomics and UBE’s New ADC Collaboration

Perseus Proteomics, Inc. (JP:4882) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Perseus Proteomics Inc. and UBE Corporation have joined forces in a new research agreement to develop antibody-drug conjugates (ADCs), focusing on the promising candidate PPMX-T004 and other exploratory ADC research. While the immediate financial impact is minimal, both companies anticipate significant long-term business growth from this collaboration.

For further insights into JP:4882 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1